Dr. Mulukutla has established himself as a well-recognized investigator in the field of cardiovascular outcomes research. His early involvement with the Dynamic Registry has resulted in several high-impact publications. He has contributed several other papers based upon the Dynamic Registry as first author, senior author, and co-author, which has earned him recognition in the Interventional Cardiology community. It was this work that largely led him to be recognized by Cardiovascular Research Technologies as one of the nation’s “Young Leaders” in 2009.
He has taken on an increased role in using system wide data across the UPMC Health System to identify opportunities for operational improvements and efficiencies within the Heart and Vascular Institute while simultaneously providing high level care to our patients. He focuses on the evaluation of cardiovascular outcomes with focus on clinical end points, cost-effectiveness, patient preferences, and quality of life as well as issues surrounding the development, introduction, and use of medical technology.
Currently, he oversees HVI Analytics and directs the HVI Center for Outcomes and Innovation. This has been responsible for the foundation for several initiatives across the health system to improve care as well as academic and research activities in outcomes across HVI. In this role, him and his team in collaboration with UPMC Clinical Analytics help others within HVI in the creation of dashboards to understand care processes and in developing datasets for analysis. These revolve around areas of clinical decision-making, readmissions in heart failure populations, treatment of complex coronary artery disease, among others.
Dr. Mulukutla's clinical area of interest is in Interventional Cardiology. His focus is on the treatment of coronary artery disease and the risk factors that lead to this condition, including hyperlipidemia, hypertension among others. He has an interest in treating patients with complex coronary disease and those presenting with acute myocardial infarction.
- BA, Cornell University, 1993
- MD, Cornell University Medical College, 1996
- Certificate in Clinical Research, University of Pittsburgh, 2004
- Residency, Internal Medicine, Boston Medical Center - Boston University, 1999
- Fellowship, Cardiology, University of Pittsburgh Medical Center, 2002
- Fellowship, Interventional Cardiology, University of Pittsburgh Medical Center, 2003
Education & Training
Sanchez CE, Dota A, Badhwar V, Kliner D, Smith AJ, Chu D, Toma C, Wei L, Marroquin OC, Schindler J, Lee JS, Mulukutla SR. Revascularization heart team recommendations as an ad-junct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease. Catheter Cardiovasc Interv. 2015; PMID 26527352
Chu D, Anastacio MM, Mulukutla SR, Lee JS, Smith AJ, Marroqin OC, Sanchez CE, Morell VO, Cook CC, Lico SC, Wei LM, Badhwar V. Safety and efficacy of implementing a multidis-ciplinary heart team approach for revascularization in patients with complex coronary artery dis-ease: an observational cohort pilot study. JAMA Surg. 2014; 149(11)__PMID: 25207883: 1109-12.
Sanchez CE, Badhwar V, Dota A, Schindler J, Chu D, Smith AJ, Lee JS, Khandhar S, Tomas C, Marroquin OC, Schmidhofer M, Bhama J, Wei L, Scolieri S, Esper S, Lee A, Mulukutla SR. Practical implementation of the coronary revascularization heart team. Circ Cardiovasc Qual Outcomes. 2013; 6(5): 598-603.
Mulukutla SR, Marroquin OC, Vlachos HA, Selzer F, Toma C, Kip KE, Abbott JD, Holper E, Lee JS, Khandhar S, Kutcher M, Kelsey S, Smith C, Faxon D, Williams DO. Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dy-namic registry. Am J Cardiol. 2013; 111(4): 486-92.
Mulukutla SR, Venkitachalam L, Bambs C, Kip KE, Aiyer A, Marroquin OC, Reis SE. Black race is associated with digital artery endothelial dysfunction: results from the Heart SCORE study. Eur Heart J. 2010; 31(22): 2808-15.
Wolf WM, Vlachos HA, Marroquin OC, Lee JS, Smith C, Anderson WD, Schindler JT, Holper EM, Abbott JD, Williams DO, Laskey WK, Kip KE, Kelsey SF, Mulukutla SR. Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circ Cardiovasc Interv. 2010; 3(1): 42-9.
Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinivas V, Kelsey SF, Kip KE. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. JACC Cardiovasc Interv. 2008; 1(2): 139-47.
Mulukutla SR, Venkitachalam L, Marroquin OC, Kip KE, Aiyer A, Edmundowicz D, Ganesh S, Varghese R, Reis SE. Population variations in atherogenic dyslipidemia: A report from the HeartSCORE and IndiaSCORE Studies. J Clin Lipidol. 2008; 2(6): 410-7.
Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL, Tanguay JF, Holper EM, Abbott JD, Lee JS, Smith C, Anderson WD, Kelsey SF, Kip KE. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med. 2008; 358(4): 342-52.
Mulukutla SR, Marroquin OC, Smith C, Varghese R, Anderson WD, Lee JS, Cohen HA, Counihan PJ, Lee AB, Gulati V, McNamara D. Effect of statin therapy prior to elective percuta-neous coronary intervention on frequency of periprocedural myocardial injury. Am J Cardiol. 2004; 94(11): 1363-6.
